Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Goshen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goshen, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 5, No. 10, 893-895, October 1999
© 1999 European Society of Human Reproduction and Embryology


Debate

What factors regulate HCG production in Down's syndrome pregnancies?

Screening for Down's syndrome using HCG concentrations – a common practice but still and enigma

Ran Goshen

Department of Biological Chemistry, The Silberman Institute of Life Sciences, The Hebrew University, Jerusalem, Israel and Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, University of Toronto, Toronto, Ontario, Canada

Trisomy 21, phenotypically manifested as Down's syndrome (DS), is the most common autosomal trisomy among live-born babies, and a major known genetic cause of mental retardation. Trisomy 21 pregnancies are associated with changes in maternal serum concentrations of human chorionic gonadotrophin (HCG) and its ß subunit. These variables are used, in combination with {alpha}-fetoprotein and oestriol, as markers for screening low-risk populations (aged <35 years) (Bogart et al., 1987Go; Haddow et al., 1992Go, 1994Go, 1998Go). In the first and second trimesters of DS pregnancies, the maternal serum concentrations of free ßHCG and total HCG respectively, are increased while free {alpha}HCG concentration is not altered (Spencer, 1993Go; Brizot et al., 1995Go). Additional markers are being investigated but these still lack any evidence for a better predictive . . . [Full Text of this Article]

Acknowledgments

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
F. Debieve, A. Moiset, K. Thomas, S. Pampfer, and C. Hubinont
Vascular endothelial growth factor and placenta growth factor concentrations in Down's syndrome and control pregnancies
Mol. Hum. Reprod., August 1, 2001; 7(8): 765 - 770.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Knofler, L. Saleh, S. Bauer, R. Vasicek, G. Griesinger, H. Strohmer, H. Helmer, and P. Husslein
Promoter Elements and Transcription Factors Involved in Differentiation-Dependent Human Chorionic Gonadotrophin-{alpha} Messenger Ribonucleic Acid Expression of Term Villous Trophoblasts
Endocrinology, October 1, 2000; 141(10): 3737 - 3748.
[Abstract] [Full Text] [PDF]